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Six-year follow-up of patients with functional bowel
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Sechs-Jahres-Nachuntersuchung bei Patienten mit funktionellen
Magen-Darm-Störungen mit und ohne vorherige Psychotherapie
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Introduction: Long-term follow-up studies in patients with functional
bowel disorders are rare.
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Zusammenfassung
Hintergrund: Langzeitstudien bei Patienten mit funktionellen Magen-
Darm-Störungen sind selten.
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Methoden: Von 85 Patienten mit funktionellen gastrointestinalen Er-
krankungen, die im Jahr 2000 diagnostiziert wurden, waren 48 sechs
Jahre später bereit, einen postalischen Fragebogen auszufüllen.
Ergebnisse: Zum Zeitpunkt der Nachuntersuchung waren die gastroin-
testinalen Beschwerden vergleichbar zum Zeitpunkt der Erstuntersu-
chung, aber Ängstlichkeit und Depression waren signifikant niedriger,
in Abhängigkeit vom Umstand, ob in der Zwischenzeit Psychotherapie
stattgefundenhatte.InsbesondereMännerprofitiertenvonderPsycho-
therapie und zeigten reduzierte Symptombelastung im Vergleich zu
Patienten, die keine Psychotherapie erfahren hatten.
Diskussion: Die psychischen Komorbiditäten (Angst und Depression)
scheinen das Konsultationsverhalten zu beeinflussen, aber von den
gastrointestinalen Symptomen und deren Schwere unbeeinflusst zu
sein. Kurzzeitige Psychotherapie trägt zu langfristigem Wohlbefinden
bei, vor allem bei Männern.
Introduction
Since the 1983 “landmark paper” by Svedlund et al. [1],
many published studies have shown that a combination
ofpsychotherapy(PT)andmedicaltreatmentorPTalone
ismoreeffectivethanconventionalmedicalmanagement
alone in the treatment of patients with functional
gastrointestinal (GI) disorders (irritable bowel syndrome,
IBS; functional dyspepsia, FD). – (For a survey, see the
reviews by Talley et al. [2], Soo et al. [3], Lackner et al.
[4], and Ford et al. [5].) A recent Cochrane meta-analysis
by Zijdenbos et al. [6] however, concluded that psycho-
logicalinterventionsmaybeslightlysuperiortousualcare
or waiting list control, but the clinical significance of this
was regarded as debatable, and the sustainability of ef-
fects as questionable. Most PT studies have followed
their patients for a few months and up to 1 year after
therapy, and long-term follow-up studies are rare [7], in
contrast to data from other clinical conditions [8], [9],
[10]. Among the exceptions is the report by Schwarz et
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therapy(CBT)andasimilarstudyfromanothergroup[12]
that followed patients up to 4 years after CBT, and 15
patients were followed for more than 2 years. Also, a 6-
year follow-up after hypnotherapy was reported in more
than 200 patients [13].
Adifferentapproachistakenbylong-term“naturalcourse
ofdisease”studiesthatfollowedpatientsforaprolonged
period of time without specific treatments. In IBS and
other functional bowel disorders, the 12-year follow-up
of patients by Halder et al. [14] may serve as one ex-
ample; others are the 5-year follow-up study by Harvey
et al. [15], the 6-year follow-up study by Neal et al. [16],
and a study by Owens et al. [17] showed some degree of
symptom improvement over time independent of a sys-
tematic trial intervention, in up to 40% of cases. These
authors did not record psychopathology in their sample
and their symptom data therefore, cannot be correlated
to psychopathology.
PTefficacyhasbeenshowntobeindependentofthetype
of PT applied, the duration of treatment and other differ-
entiating variables [4]. If at all, variables predicting
treatment success were identified in relation to clinical
symptom severity (with the most severe symptoms pre-
dicting less success) and psychopathology (the higher
the psychic comorbidity the better the PT response). A
recent analysis by Lackner et al. [18] investigating mod-
erators of treatment success came to conclude that PT
directly affects gastrointestinal symptoms rather than
being mediated via improvement of psychological well-
being. However, many PT treatment reports are often
lacking appropriate control groups and may be regarded
asprovidinginappropriateevidenceforefficacyofPT[2],
[3], [4], [5], [6].
In a recently published paper from our group [19] we
could show that one of the mediators of PT treatment
success is the patients' motivation to undergo PT. How-
ever, whether patients were asked for their motivation or
whether motivation was measured on psychometric test
scales would not predict their actual behaviour to accept
PT when this was offered. In our study, only a minority of
patients(19%)acceptedtheofferofundergopsychother-
apy. We followed the patients from this cohort six years
later and asked for their current symptoms and psycho-
logical profiles to compare those that had undergone PT
to those that did not. However, we acknowledge that our
design resembles rather that of “natural history” studies
than of “long-term psychotherapy outcome” studies.
Methods
Patients
Consecutive patients with symptoms suggestive of func-
tional gastrointestinal disorders who were seen between
January 1999 and December 2000 were included into
the study. The Ethics Board of the University Hospital
Heidelberg had approved the study; all patients gave
written informed consent prior to participation.
Allpatientswereseeninthegastroenterologicoutpatient
clinic by a gastroenterologist, who suggested another
consultation by a medical doctor trained in internal and
psychosomatic medicine because of the nature of their
symptoms. This physician recommended psychotherapy
in all cases after the consultation.
In cases of symptoms suggestive of FGD, routine gastro-
enterologicaldiagnosticprocedures[20],[21]wereused
to exclude an organic origin of symptoms. Patients self-
rated the presence and severity of the following GI
symptoms – in accordance with the Rome definition of
functional GI disorders [22] – and related symptoms. All
symptoms were rated between 0 = not at all present and
4 = very strong. A questionnaire asked for the patients'
actual social and biographic background (education,
profession, current family situation, current employment
status/retirement), medical history (current medication,
frequency of doctor visits, inpatient treatments), and
previous psychotherapy. They were also asked whether
they had consulted doctors, psychotherapists, and alter-
native medicine practitioners since the initial evaluation.
Inaddition,patientsreceivedapsychometrictestbattery
including the Giessen Somatic Complaints Scale (GBB)
[23],[24],andtheGermanversionoftheHospitalAnxiety
and Depression Scale (HADS) [25], [26].
Psychotherapy
Patientswereofferedtoparticipateina10-sessiongroup
therapy(90min/sessionweekly)withinthesettingofthe
GI hospital. Following the assessment of individual ther-
apy goals according to the Goal Attainment Scaling [27],
patients were informed about the disease, prognosis,
diagnosisandcurrentstateoftherapy,learnedtoconduct
a symptom diary, and to perform muscle relaxation
training according to Jacobson. They learned to identify
symptom-provoking situations, and to develop and exer-
ciseindividualproblemsolvingstrategies,andbehavioural
alternativestocopewithstress.Theyalsowereinstructed
in nutritional and dietary management of symptoms. To
include the familial environment and problems into
treatment, family members were invited for an initial as-
sessmentandforonegrouptherapysession.Asreported
previously [19], 16 patients of the initial cohort partici-
patedina10-hoursupportiveeducationalpsychotherapy
according to a published scheme [28].
Patientswhounderwentpsychotherapyinthelast6years
received either cognitive behavioral psychotherapy or
psychodynamic psychotherapy because these methods
are paid by the German health care insurances. 1/3 had
weekly sessions, and nearly 30% had psychotherapy for
one year. 1/4 of patients consulted alternative medicine
practitioners.
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The GBB scale [23], [24] is used to record the bodily
complaints of patients with somatic disorders. It allows
distinguishing between organically generated symptoms
and subjective complaints.
Hospital Anxiety and Depression Scale (HADS)
The HADS [25], [26] is a fourteen-items instrument to
assess anxiety and depression in patients with somatic
diseases; the German version (HADS-D) was developed
for use in general medicine.
Follow-up
In 2006, all patients included in the initial study were
mailed a set of tests and questionnaires; these included
the GI symptom rating scale, the GBB, and the HADS.
Patientswhodidnotrespondwithin2weeksaftermailing
were followed by telephone survey to identify the reason
for their non-responsiveness.
Evaluation and statistics
Social and medical history data were analysed in a qual-
itative and quantitative fashion. Symptom severity was
scored by adding the presence and severity of 11 GI re-
lated symptoms (abdominal pain, bloating, feeling of
distension, feeling of incomplete evacuation, diarrhoea,
undigested food in stool, mucus in stool, constipation,
loss of appetite, nausea) that were rated between 0 (not
present) and 4 (severe). Psychometric data were scored
accordingtothestandardsoftherespectivetests.Change
in marital and professional status was noted if present;
in addition, we assessed whether patients had experi-
enced PT in-between the two evaluation points, and
computed the total number of patients with PT experi-
ence.
Clinical symptom scores and psychometric scores were
compared within patients by 2x2 repeated-measure
ANOVAsusingtime(pre,post)aswithin-factorandgender
(male, female) as between factor. PT (yes, no), change
of marital status (yes, no) and retirement (yes, no) as
between-subject factors that were added individually to
post-hocexploretheircontributiontoGIandpsychometric
symptoms changes over time.
Association between repeated measures of individual
testswereevaluatedbyPearson'scorrelationcoefficient.
Alldatareportedaremean±SD.Alltestswereperformed
using the SPSS Version 13 statistical package on an IBM
PC; for all tests, the level of significance was set at 5%.
Results
Of the initially evaluated 85 patients (49.1 years, 61:24
females:males) with the diagnosis of “somatoform auto-
nomic disorder of the upper gastrointestinal tract” (ICD-
10 F.45.31, n=13) or “somatoform autonomic disorder
ofthelowergastrointestinaltract”(ICD-10F.45.32,n=40)
or both (n=32), 48 (56%) were available for the follow-up
investigation. However, excluding those with missing
contact addresses, those that had received other diag-
noses, and one patient who had died, response rate was
48/69 (70%) (Figure 1).
Figure 1: CONSORT chart of patient inclusion/exclusion.
Response rate was 58% based on the initial recruitment and
70%basedonthenumberofpatientswhowereaccessiblefor
follow-up evaluation.
Socio-demographic and clinical characteristics of the 48
patients are summarized in Table 1. Patients who parti-
cipated in the follow-up were not different from those
who did not with respect to their psychological profiles at
theinitialinvestigation.Ascanalsobeseen,patientswho
had participated in initial PT (n=11) were not different
from those who had not; the same holds true when all
patients with PT experience (initially as well as over the
6 years follow-up, see below) (n=31) were compared to
those who did not.
It was noted that 13 patients had changed their family
status during the follow-up period; in 10 cases they
changed from single to married, and in one case each
from married to separated, from married to re-married,
and from married to widowed. Sixteen patients were re-
tiredorsemi-retiredatfollow-upcomparedtoonesubject
at the initial assessment. Three patients had finished
schoolin-between,6morehadupgradedtheirprofession-
al qualification.
Nearly all patients in both groups had been seen by gen-
eral practitioners and/ore specialists since the initial
evaluation, and 1/3 had consulted one or more alterna-
tive practitioner. In addition, 25 patients (5 males, 20
females) had been in PT in-between (7 on an inpatient
basis, 14 as outpatients, and 4 with both), and 14/25
were cases in which PT had not been experienced at the
time of the initial evaluation. At follow-up, 31 patients
(64.6%) (8 males, 23 females) had collected PT experi-
ence over the 6 years.
Twentypatientshadusedgastroenterologicalmedication
during follow-up (5 proton pump inhibitors, 6 antacids,
3antispasmodics,2antidiarrhoealdrug,somelaxatives),
and 16 patients had used or used currently antidepress-
antmedication(onepatientwithacombinationofantide-
pressant and neuroleptic medication).
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Gastrointestinal Symptoms
At the initial evaluation, patients reported an average
15.9±1.1 points on the 0 to 44 symptom scale, while at
follow-up, they scored 14.9±1.2 points; this difference
was not significant (2x2 ANOVA, not significant). Both
measures correlated high and positively: r=.539, p<.001
indicating that a high symptoms load at the initial evalu-
ation would also be present at follow-up; while many pa-
tients had changed symptoms, these changes occurred
in both directions. Patients who had undergone PT were
equally distributed among them (Figure 2, Table 2).
ANOVA revealed a significant interaction between the
factors “time” (pre, post), gender (males, females) with
initial PT (yes, no) (significant interaction: F=4.189,
p=.047)(Figure3)aswellasforPTbetweenassessments
(F=4.401, p=.042) indicating that men that had partici-
patedinPTreducedGIsymptomsmorepronouncedthan
women, while this gender difference was not seen in
those without PT experience.
Patients who had participated in PT initially showed
overall significantly higher symptoms initially as well as
at follow-up (main effect of PT: F=4.678, p=.036) than
those who did not. Male patients who had participated
inPTduringthefollow-upperiodshowedlowersymptoms
at follow-up (significant interaction “time x gender x PT
in-between”, F=4.401, p=.042). Change of marital and
job status did not contribute to GI symptoms and symp-
tom changes.
Figure 2: Scatter plot of gastrointestinal symptom scores at
initial evaluation and at follow-up. Pearson's correlation
coefficient was R=.539, p<.001. Black diamonds indicate
patientswhounderwentpsychotherapyeitherinitiallyorduring
follow-up (n=31), open circles patients who did not; a black
filledcirclerepresentstwooverlappingcaseswithandwithout
psychotherapy experience.
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Figure3:Totalgastrointestinalsymptomscoreatinitialevaluationandatfollow-upbygenderandbetweenpatientswith(n=31)
orwithoutpsychotherapy(n=17).ANOVArevealedasignificantinteractionbetweenthefactors“time”(pre,post),gender(males,
females) and PT (yes, no) (F=4.401, p=.042).
GBB scores
Total GBB scores decreased over time (main effect:
F=7.755, p=.067), and were more pronounced for GI
symptoms (F=9.922, p=.003) than for fatigue (F=8.585,
p=.005), cardiac (F=4.653, p=.036), and muscular
symptoms (not significant). PT experience did affect
neitherofthesescores,andneitherdidchangeofmarital
status.Retirementtendedtohaveanindependenteffect
on total GBB scores (main effect: F=3.867, p=.056): Pa-
tients who had retired in the interim between initial
evaluation and follow-up demonstrated higher overall
GBB scores than those who did not.
HADS anxiety and depression
HADS anxiety scores tended to be lower at follow-up, as
revealed by repeated measure ANOVA (main effect of
time: F=2.903, p=.095).
When PT was entered into the equation a significant
interaction between time, gender, and PT occurred
(F=4.261, p=.042) with men who had participated in the
PT showing less symptoms. This was due to initial PT
(F=4.589, p=.038), while PT experience during follow-up
did not contribute to anxiety changes. Change of marital
status independently tended to improve of HADS anxiety
scores (main effect: F=3.757, p=.059) while retirement
did not.
In general, depression scores did not change much over
time (Table 2).
Inter-correlations
HADS scores as well as and GBB total score correlated
high between the first evaluation and at follow-up (Table
2). All changes of symptoms and HADS and GBB scores
between first assessment and follow-up were also signi-
ficantly correlated (Table 3).
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Discussion
To summarize the findings of our study, we found that 6
years after initial evaluation, patients with functional
bowel disorders exhibited a similar number and severity
of gastrointestinal symptoms but had substantially im-
proved the anxiety and depression scores. In men but
not in women, this decrease in anxiety and a moderate
symptom improvement was associated with the partici-
pation in psychotherapy 6 years ago or during the follow-
up period. However, significant interactions of PT experi-
ence were found with gender and overall GI symptoms
andGBBandHADSscores,indicatingthatespeciallymen
profitedfromPTexperienceinthepast.Wecouldnotfind
support for the notion that symptomatic improvements
may as well be due to changes in family and professional
status, except that the initial symptom burden (in the
GBB) was higher in those that had retired at follow-up.
While there are many long-term follow-up studies of PT
in various clinical conditions [8], [9], [10], only a few of
the PT treatment studies with functional bowel disorders
report data for more than one year after therapy. Among
the few, the report by Schwarz et al. [11] summarizes all
measures at a 4-year follow-up of cognitive-behavioural
therapy (CBT) in 19 patients to be lower than those ob-
tained prior to treatment, and significant reductions on
key IBS symptoms such as diarrhoea, nausea, and flatu-
lence. A similar study from another group [12] reported
similar follow-up data for 32 patients after up to 4 years
after CBT, and 15 patients were followed for more than
2 years. The sustained response of PT on anxiety symp-
toms we report at least in men is compatible with these
data,butbeyondthisbothstudydataarenotcomparable
toourassessmenthereastheybothincludedwaitinglist
controlsthatreceivedPTafterthestudytermination,and
they did not include a no-treatment control group. A dif-
ferent approach in FBD patients is the application of gut-
directed hypnosis: Gonsarkonsale et al. [13] reported
that from the initial 70% responders to therapy, 80% had
persistent symptom improvement up to 5 years later.
Improvement was related to quality of life for the entire
period with psychological burden, extraintestinal symp-
toms,andnumberofphysicianconsultationssubstantially
reduced.Contrarytopreviousresults,ageandpsychiatric
comorbidity had no influence on the success rate.
It has been stated before that establishing of unspecific
(placebo) effects in clinical trials would require “no
treatment” control groups to allow the separation of
specific therapy effects from spontaneous variation of
symptomsandfrom“true”placebo(orunspecific)therapy
effects [29]. Such data do – to our knowledge – not exist
for psychotherapy trials but can be found in epidemio-
logical samples. In IBS and other functional bowel dis-
orders, the 12-year follow-up of patients by Halder et al.
[14] may serve as one example; others are the 5-year
follow-upstudybyHarveyetal.[15],andthe6-yearfollow-
up study by Neal et al. [16]. However, the study by Harvey
et al. [15] was based on an IBS definition that does not
comply with current or previous IBS definitions [12] and
followed only 104 patients who had been treated for IBS.
Overall, 68% of patients were reported to be symptom
free after 5 years. In a similar study by Owens et al. [17],
112 patients who had been diagnosed having IBS were
followed for a medium of 29 (range: 1 to 32) years; IBS
patients had a positive prognosis and fewer follow-up
visits in case the records contained (among others) in-
formation about the patients psychosocial history, indi-
cating a strong physician-patient interaction. The study
by Neal et al. [16] followed 192 patients who had previ-
ously experienced an episode of acute enteritis to deter-
mine, who would develop new IBS symptoms (n=14);
hence, their data are non conclusive for our research
question. All other studies had a follow-up of mostly 1
year after therapy or diagnosis.
In the largest “natural history” epidemiological study by
Halder et al. [14], the authors followed more than 1,300
patients with symptoms of IBS and/or FD for 12 years
and found that about 40% of their sample had lost their
GI symptoms at follow-up, while 20% had similar com-
plaintsandanother40%hadchangedtheirpredominant
complaintsfromuppertolowerGItractsorreverse.Such
a change of diagnostic group had been noted before but
forshorterfollow-upperiods[30],[31]andwasattributed
to an underlying common pathogenesis of FGD [32].
These authors did not record psychopathology in their
sample and their symptom data therefore, cannot be
correlatedtopsychopathology,aswedid;butothershave
reported that psychopathology determines health care-
seeking behaviour, symptom severity and duration, and
psychological and somatic comorbidity [33], [34], [35].
Unfortunately,ourfollow-updatadonotallowtheassess-
ment of such a transition of diagnostic groups. Other
limitations of our study are the small sample size (and
thelowpowerofthestatisticalanalysis)andthefactthat
a patient population recruited at a tertiary centre does
notrepresentallpatientswithfunctionalboweldisorders
and may include a subset of patients with high morbidity
and longer illness history, but this certainly does apply
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demiccentres.Wealsodonotknowwhetherandtowhat
extend our IBS patients did require medical care for GI
symptoms between the initial evaluation and the follow-
up; however, we could identify a substantial group of pa-
tientswhounderwentadditionalpsychotherapysessions,
and that contributed to the treatment success as much
as the initially PT treatment. As has been reported in the
literature,predictionoftreatmentoutcomeappearsdiffi-
cult, and may be related to individual features not
sampled in our study. Finally, patients may have used
antidepressants during the follow-up period in parallel to
psychotherapy, and that could have contributed to the
reportedchangesespeciallywithrespecttopsychological
improvements, but was not assessed with our question-
naire.
In summary we conclude that over the course of 6 years
GI symptoms in IBS exhibit a rather stable pattern, but
atthesametimepsychologicalsymptoms(somatization,
anxiety and depression) improve, especially in those pa-
tients who underwent psychotherapy; among them, men
profited more. While only 11 patients had agreed to PT
during the first phase of the study [9], another 20 under-
went PT during the follow-up period. Both the initial
symptom load as well as continuous psychological and
gastrointestinalsymptomsduringthefollow-upmayhave
motivated patients to take advantage of PT.
As we have stated before [32], patients with functional
gastrointestinal disorders are not a homogeneous group
of patients even when they enter a specialised tertiary
centre. Gender, motivation, psychological strain and
severity of symptoms contribute to their health care
seeking behaviour, but also to therapy outcome. Further
research on therapy effects in subpopulations, stratified
for psychological comorbidity, gender, and chronicity of
symptoms) is needed to eventually overcome these limi-
tations.Inclinicalpracticeshort-termmultimodaltherapy
shouldbeofferedtomotivatepatients,inparticularmale
patients who usually have more problems accepting
psychotherapy, but – as shown in this study – benefit
more than expected once they agree to participate.
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